0
 

Laboratorios Valmorca, C.A.-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

  • ID: CPS_IC_176726
  • July 2017
  • 8 pages
  • Price: $ 95
 
 

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.

 

TOC

1.1 Company Overview

1.2 Company Snapshot

1.3 Operating Business Segment

1.4 Business Performance

1.5 Key Strategic moves and Development

 

LIST OF TABLES AND FIGURES

TABLE 1. COMPANY SNAPSHOT OF LABORATORIOS VALMORCA

TABLE 2. LABORATORIOS VALMORCA OPERATING SEGMENTS

Purchase Options

 

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers